Prevalence of Chlamydophila pneumoniae is higher in aorta and coronary artery than in carotid artery of coronary artery disease patients

APMIS

Volumn 117, Issue 12, 2009, Pages 905-911

  Jha, Hem C ^a   Srivastava, Pragya ^a   Divya, Aabha ^b   Prasad, Jagdish ^a   Mittal, Aruna ^a  

^a SAFDARJUNG HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

16S rRNA; Chlamydophila pneumoniae; Cytomegalovirus; Helicobacter pylori; Multiplex PCR; Real time PCR

Indexed keywords

IMMUNOGLOBULIN A;

ADULT; AORTA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BACTERIUM DETECTION; CAROTID ARTERY; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; FEMALE; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN TISSUE; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PERSISTENT INFECTION; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

ADULT; ANTIBODIES, BACTERIAL; AORTA; CAROTID ARTERIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY DISEASE; CORONARY VESSELS; CYTOMEGALOVIRUS; FEMALE; HELICOBACTER PYLORI; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 70450190172     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2009.02553.x     Document Type: Article

References (34)

1. Boudík F, Reissigova J, Hrach K, Tomeckova M, Bultas J, Anger Z, et al. Primary prevention of coronary artery disease among middle aged men in Prague: twenty-year follow-up results. Atherosclerosis 2006 184 : 86 93.
2. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998 97 : 596 601.
3. Jasvinder KG, Kaur H, Prabhu KM. Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians. Clin Biochem 2008 41 : 453 458.
4. Markus HS, Carrington MD, Steinmetz MA. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. Circulation 1999 100 : 832 837.
5. Nicholson AC, Hajjar DP. Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? Arterioscler Thromb Vasc Biol 1998 18 : 339 348.
6. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993 362 : 801 808.
7. Schoenbeck U, Mach F, Sukhova GK, Murphy C, Bonnefoy J-Y, Fabunmi RP, et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by t-lymphocytes: a role for cd40 signaling in plaque rupture? Circ Res 1997 81 : 448 454.
8. Vercellotti GM. Effects of viral activation of the vessel wall on inflammation and thrombosis. Blood Coagul Fibrinolysis 1998 9 : S3 6.
9. Yamashiroya HM, Ghosh L, Yang R, Robertson AL. Herpesviridae in coronary vessels and aorta of young trauma victims. Am J Pathol 1998 130 : 71 8.
10. Saikku P, Leinonen M, Mattila K, Huttunen JK, Leinonen M, Ekman MR, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988 2 : 983 986.
11. Sessa R, Schiavoni G, Di PM. Chlamydia pneumoniae in PBMC: reproducibility of the OMPA nested touchdown PCR. Int J Immunopathol Pharmacol 2005 18 : 113 120.
12. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997 96 : 2144 2148.
13. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999 100 : e20 8.
14. Fong IW. Infections and their role in atherosclerotic vascular disease. J Am Dent Assoc 2002 133 : 7S 13S.
15. Joseph AV, Loscalzo J. Shouldering the risk factor burden: infection, atherosclerosis, and the vascular endothelium. Circulation 2002 106 : 164 166.
16. Arav-Boger R, Pass R. Viral load in congenital cytomegalovirus infection. Herpes 2007 14 : 17 22.
17. Saldanha CE, Lubinski J, Martin C, Nagashunmugam T, Wang L, Key HVD, et al. Herpes simplex virus type 1 glycoprotein e domains involved in virus spread and disease. J Virol 2000 74 : 6712 6719.
18. Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001 103 : 45 51.
19. Siobhan OC, Taylor C, Campbell LA. Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg Infect Dis 2001 7 : 780 788.
20. Espinola-Klein C, Hans-Jurgen R, Stefan B, Christoph B, Helmuth K, Gerd R, et al. Are morphological or functional changes in the carotid artery wall associated with Chlamydia peumoniae, Helicobacter pylori, cytomegalovirus, or herpes simplex virus infection? Stroke 2000 31 : 2127 2133.
21. Juul N, Jensen H, Hvid M. Characterization of in vitro chlamydial cultures in lower oxygen atmospheres. J Bacteriol 2007 189 : 6723 6726.
22. Gaydos CA. Growth in vascular cells and cytokine production by Chlamydia pneumoniae. J Infect Dis 2000 181 : S473 8.
23. Blasi F, Aliberti S, Allegra L, Piatti G, Tarsia P, Ossewaarde JM, et al. Chlamydophila pneumoniae induces a sustained airway hyper responsiveness and inflammation in mice. Resp Res 2007 8 : 83.
24. Jha HC, Vardhan H, Gupta R, Varma R, Prasad J, Mittal A. Higher incidence of persistent chronic infection of Chlamydia pneumoniae among cad patients in India is a cause of concern. BMC Infect Dis 2007 7 : 48.
25. Jha HC, Prasad J, Mittal A. High IgA seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection and high sensitive C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker. Heart Vessels 2008 23 : 390 396.
26. Ossewaarde JM, Feskens EJM, De vries A, Vallinga CE, Kromhout D. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 1998 120 : 93 9.
27. Joseph BM, Anderson JL. Infectious serology and atherosclerosis: how burdensome the risk? Circulation 2003 107 : 220 222.
28. Peeling RW, Brunham RC. Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis 1996 2 : 307 319.
29. Sheehan J, Kearney PM, Sullivan SO, Mongan C, Kelly E, Perry IJ. Acute coronary syndrome and chronic infection in the cork coronary care case-control study. Heart 2005 91 : 19 22.
30. Sessa R, Pietro MD, Schiavoni G. Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease. Atherosclerosis 2007 195 : e224 30.
31. Jackson LA, Campbell LA, Schmidt RA, Kuo CC, Cappuccio AL, Lee MJ, et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol 1997 150 : 1785 1790.
32. Cochrane M, Pospischil A, Walker P, Gibbs H, Timms P. Distribution of Chlamydia pneumoniae DNA in atherosclerotic carotid arteries: significance for sampling procedures. J Clin Microbiol 2003 41 : 1454 1457.
33. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992 116 : 273 278.
34. Marrie TJ, Peeling RW, Reid TE, Carolis D. Acquired pneumonia investigators Chlamydia species as a cause of community-acquired pneumonia in Canada. Eur Respir J 2003 21 : 779 784.